HIP
TEVA icon

Hatteras Investment Partners’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Hatteras Investment Partners’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-29,598
Closed -$1.84M – 131
2015
Q1 		$1.84M Buy
+29,598
New +$1.72M 0.99% 34

Other funds holding TEVA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return
Waddell & Reed Financial
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Mondrian Investment Partners
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return
BlackRock Advisors
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return
PointState Capital
PointState Capital New York $7.82B AUM 43.51% 1-Year Est. Return

Hatteras Investment Partners's TEVA Position: Q2 2015 in Review

Hatteras Investment Partners sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q2 2015, closing a stake of 29,598 shares — an estimated $1.84M sold.

Hatteras Investment Partners first reported a position in TEVA in Q1 2015 and held it in 1 quarter. The position peaked at $1.84M in Q1 2015. 819 funds tracked by Wall St. Rank hold TEVA as of Q2 2015.

  • Hatteras Investment Partners reported no remaining Teva Pharmaceutical Industries Limited position as of Q2 2015 after selling out during the quarter.
  • Hatteras Investment Partners sold 29,598 Teva Pharmaceutical Industries Limited shares in Q2 2015, an estimated $1.84M.
  • Hatteras Investment Partners first reported a position in Teva Pharmaceutical Industries Limited in Q1 2015 and held it in 1 quarter.
  • Hatteras Investment Partners's Teva Pharmaceutical Industries Limited position peaked at $1.84M in Q1 2015.
  • 819 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q2 2015.

Based on Hatteras Investment Partners's 13F filing for Q2 2015, filed 13 Aug 2015.